Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Lassen

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Journal of Thrombosis and Haemostasis : JTH|March 21, 2012
Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEEM R Lassen, W Fisher, P Mouret, et al.
The Journal of Laboratory and Clinical Medicine|August 12, 1999
Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjectsE A Braat, M Levi, R Bos, et al.
Ugeskrift for Laeger|April 12, 1993
[Low molecular heparin in prevention of thrombosis in orthopedic surgery]H P Jensen, L C Borris, M R Lassen, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2007
Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory studyB I Eriksson, O E Dahl, M R Lassen, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 1, 1992
Phlebography as the gold standard in thromboprophylactic studies? A multicenter interobserver variation studyP Wille-Jørgensen, L Borris, L N Jørgensen, et al.
The Journal of Bone and Joint Surgery. British Volume|October 31, 2012
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programmeM R Lassen, M Gent, A K Kakkar, et al.
Thrombosis Research|July 1, 1990
Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis--influence of prophylaxis with a low molecular weight heparin. The Venous Thrombosis GroupJ V Sørensen, L C Borris, M R Lassen, et al.
The Journal of Bone and Joint Surgery. British Volume|February 11, 2012
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trialsG E Raskob, A S Gallus, G F Pineo, et al.
Haemostasis|January 1, 1992
Potential influence of observer variation in thromboprophylactic trialsP Wille-Jørgensen, L C Borris, M R Lassen, et al.
The International Journal of Risk & Safety in Medicine|March 21, 2013
Survival in patients undergoing total hip arthroplasty in relation to thromboprophylaxis with low molecular weight heparin: a long-term follow-up studyB S Andersen, H P Jensen, L C Borris, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Journal of Thrombosis and Haemostasis : JTH|March 21, 2012
Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEEM R Lassen, W Fisher, P Mouret, et al.
The Journal of Laboratory and Clinical Medicine|August 12, 1999
Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjectsE A Braat, M Levi, R Bos, et al.
Ugeskrift for Laeger|April 12, 1993
[Low molecular heparin in prevention of thrombosis in orthopedic surgery]H P Jensen, L C Borris, M R Lassen, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2007
Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory studyB I Eriksson, O E Dahl, M R Lassen, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 1, 1992
Phlebography as the gold standard in thromboprophylactic studies? A multicenter interobserver variation studyP Wille-Jørgensen, L Borris, L N Jørgensen, et al.
The Journal of Bone and Joint Surgery. British Volume|October 31, 2012
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programmeM R Lassen, M Gent, A K Kakkar, et al.
Thrombosis Research|July 1, 1990
Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis--influence of prophylaxis with a low molecular weight heparin. The Venous Thrombosis GroupJ V Sørensen, L C Borris, M R Lassen, et al.
The Journal of Bone and Joint Surgery. British Volume|February 11, 2012
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trialsG E Raskob, A S Gallus, G F Pineo, et al.
Haemostasis|January 1, 1992
Potential influence of observer variation in thromboprophylactic trialsP Wille-Jørgensen, L C Borris, M R Lassen, et al.
The International Journal of Risk & Safety in Medicine|March 21, 2013
Survival in patients undergoing total hip arthroplasty in relation to thromboprophylaxis with low molecular weight heparin: a long-term follow-up studyB S Andersen, H P Jensen, L C Borris, et al.
Pageof 7